ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Internal Medicine

Top Internal Medicine Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IOANA PAHLEVAN MD

Internal Medicine

24,257

$818K

1338
1108 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$34
Average prescription price

Avg: $54

APRIL NEUMANN MD

Internal Medicine

22,326

$706K

802
703 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$32
Average prescription price

Avg: $54

MARIA MOLINA MD

Internal Medicine

21,768

$861K

1225
1074 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $54

PATRICK TICMAN MD

Internal Medicine

21,530

$830K

1363
1190 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $54

GOPALAKRISHNA LEELA MD

Internal Medicine

21,438

$788K

318
265 are 65+

24%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $54

DMITRIY KOSYAGIN MD

Internal Medicine

21,290

$784K

1226
1118 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $54

ASMA HABIB MD

Internal Medicine

20,711

$899K

1191
1044 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $54

NEETA SONI MD

Internal Medicine

20,139

$669K

1161
1072 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $54

JOHN WATSON MD

Internal Medicine

19,358

$955K

801
491 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $54

DANIEL MALONE MD

Internal Medicine

19,005

$649K

1155
1047 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$34
Average prescription price

Avg: $54

JOSEPH CAIMOL MD

Internal Medicine

18,864

$653K

994
831 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $54

VENUMBAKA REDDY MD

Internal Medicine

18,752

$625K

1373
1220 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $54

AFI BRUCE MD

Internal Medicine

18,741

$810K

1111
942 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $54

VALERIA ASIMENIOS MD

Internal Medicine

18,269

$645K

1127
1020 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $54

ABHINAV SINHA M.D.

Internal Medicine

17,518

$871K

455
210 are 65+

44%
patients receiving schedule two controlled substances

Avg: 7%

42%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $54

GERARDO LORENZANA MD

Internal Medicine

16,815

$703K

1670
1508 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $54

YOLANDA FLORES MD

Internal Medicine

15,932

$667K

1004
920 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $54

RAN JIA M.D.

Internal Medicine

15,887

$579K

935
811 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $54

ALOK SAXENA M.D.,

Internal Medicine

15,068

$773K

341
270 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $54

JERRY CHIEN MD

Internal Medicine

14,803

$467K

830
676 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$32
Average prescription price

Avg: $54

BERNARD BARTOLOME M.D.

Internal Medicine

14,662

$878K

551
374 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

25%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $54

TIM NGUYEN MD

Internal Medicine

14,483

$584K

955
847 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $54

QUI THAI MD

Internal Medicine

14,152

$671K

252
189 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $54

MAJONEL ONTANILLAS MD

Internal Medicine

14,096

$489K

874
736 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $54

CRAIG JORGENSON MD

Internal Medicine

13,674

$480K

397
356 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $54

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank